Applications of Boc-D-Phg-OH in Industrial Manufacturing

Boc-D-Phg-OH (N-tert-butoxycarbonyl-D-phenylglycine) is a specialty protected amino acid widely used across advanced peptide synthesis, pharmaceutical APIs, and fine chemical preparations. As the direct manufacturer, we supply this material in grades suited for precise industrial applications, with strict lot-to-lot quality control and tailored documentation to support regulatory and process validation in each segment.

1. Peptide Active Pharmaceutical Ingredient (API) Synthesis

Pharmaceutical producers use Boc-D-Phg-OH for solid-phase and solution-phase peptide synthesis, particularly to incorporate the D-phenylglycine moiety into complex APIs such as glycopeptide antibiotics and custom peptide drugs. The material’s protection group ensures defined incorporation, enabling high-purity synthesis necessary for regulated pharmaceutical environments. Our technical and QC support includes impurity profiling and batch-specific documentation for process development through to scale-up.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 210/211 (US FDA GMP for finished pharmaceuticals)
• European Pharmacopoeia (Ph. Eur.) monographs for protected amino acids
• USP General Chapter <1092> for peptide APIs

Typical usage ratio

• 1.0 – 1.2 molar equivalents per coupling step, adjusted for resin loading and sequence requirements in each batch

Downstream process integration

• Direct coupling via carbodiimide or uronium chemistries on resin-bound or solution-phase peptides during elongation cycles
• Cleavage and deprotection under acidic conditions to remove Boc after chain assembly

Final product types

• Peptide-based APIs (e.g., glycopeptide antibiotics, receptor antagonists)
• Custom pharmaceutical peptides
• Reference standards for analytical testing
• Preclinical and clinical peptide intermediates

2. Chiral Intermediate for Small Molecule Drug Synthesis

Medicinal chemistry labs and scale-up teams use this raw material as a chiral building block to introduce the D-phenylglycine motif into advanced small molecule intermediates. The Boc protection provides high stability for multi-step synthesis routes involved in the development and launch of enantiomerically pure drugs, such as certain antibiotics and antiviral agents. Detailed CoA and chiral purity assessment support customer method validation and registration submissions.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• USP general requirements for pharmaceutical-grade intermediates
• GMP guidelines for starting materials (as adopted by EMA and FDA)

Typical usage ratio

• 10–25% w/w of total reaction mass, with ratio adjusted per synthetic route and desired intermediate yield

Downstream process integration

• Used as a chiral precursor in amidation or esterification stages
• Incorporated before deprotection and further functionalization steps

Final product types

• β-lactam antibiotic intermediates
• Chiral auxiliaries for antiviral drug candidates
• Pharmacopeial quality intermediates for final API synthesis
• Chemical reference materials for enantiomer separation

3. Custom Peptide Manufacturing for Diagnostic Reagents

Manufacturers producing synthetic peptides for diagnostic ELISA kits, immunoassays, and analytical controls use this D-phenylglycine derivative to introduce stereospecific amino acid residues into target peptides. The product’s consistent purity and controlled particle size support automated peptide synthesizer loading and ensure effective coupling yields in scale production. Technical support covers peptide mapping and batch traceability for ISO-accredited environments.

Industry compliance standards

• ISO 13485:2016 for In Vitro Diagnostic (IVD) medical device manufacturing
• 21 CFR Part 820 Quality System Regulation (QSR) for diagnostics
• International Council for Standardization in Analytical Chemistry (IUPAC) recommendations for peptide standards

Typical usage ratio

• Exact molar equivalent per defined D-phenylglycine position in peptide sequence; typically 1:1 stoichiometry

Downstream process integration

• Loaded onto automated or semi-automated peptide synthesizers during sequence assembly
• Boc-deprotection performed prior to cyclization or terminal modification for diagnostic use

Final product types

• Peptide controls for immunoassay calibrators
• Synthetic antigens for ELISA kit production
• Custom diagnostic peptides for clinical labs
• Peptide mapping standards for LC-MS analysis

4. Building Block for Specialty Chemical Synthesis

Fine chemical and research manufacturers utilize this protected amino acid as a modular synthon to prepare specialty reagents, asymmetric catalysts, or molecular scaffolds where D-configured aromatic amino acid units are essential. In this sector, performance factors like batch homogeneity, low water content, and pre-defined impurity profiles drive process consistency. Bulk supply and scale-specific QC accompany technical consultation for protocol optimization.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for chemical production
• Responsible Care and chemical stewardship principles
• REACH (EC) No 1907/2006 compliance for EU-bound shipments

Typical usage ratio

• 5–35% of reaction mixture, regulated according to the target molecule’s substitution pattern and scale

Downstream process integration

• Introduced during nucleophilic or electrophilic substitution steps for molecular scaffold assembly
• Protecting group remains intact until final deprotection to preserve stereochemistry

Final product types

• Aromatic peptide-mimetic ligands
• Asymmetric catalytic agents for organic transformations
• Synthetic intermediates for material science research
• Custom fine chemicals with chiral control